Proprietary alpha-amylase inhibitor formulation from white kidney bean (Phaseolus vulgaris L.) promotes weight and fat loss: a 12-week, double-blind, placebo-controlled, randomized trial

Ralf Jäger,Sidney Abou Sawan,Martin Purpura,Barbara Grube,Yvette Röske,Patricia De Costa,Pee-Win Chong

DOI: https://doi.org/10.1038/s41598-024-63443-8

IF: 4.6

2024-06-05

Scientific Reports

Abstract:White kidney bean ( Phaseolus vulgaris L.) extracts can aid weight management by reducing calorie intake from complex carbohydrates through alpha-amylase inhibition. We examined the impact of a proprietary aqueous extract from whole dried white kidney beans standardized by its alpha-amylase inhibitor activity (Phase 2 white kidney bean extract (WKBE)) on weight management in subjects with overweight and moderate obesity. In a randomized, double-blind, placebo-controlled fashion, 81 participants completed the study and ingested either a high dose of Phase 2 (1000 mg, WKBE HIGH), a low dose (700 mg, WKBE LOW), or a matching placebo (microcrystalline cellulose, PLA) three times a day, 30 min before meals, for 12 weeks during a calorie restricted diet. In a dose-dependent manner, Phase 2 significantly reduced body weight, fat mass, BMI, waist, hip and in the WKBE HIGH group thigh circumference. Phase 2 is an effective and safe supplement aiding weight and fat loss. ClinicalTrials.gov identifier NCT02930668.

multidisciplinary sciences

What problem does this paper attempt to address?

The study aims to investigate the effects of a proprietary white kidney bean (Phaseolus vulgaris L.) extract—Phase 2 white kidney bean extract (WKBE) on weight management in overweight and moderately obese individuals. The research employed a double-blind, placebo-controlled, randomized trial design, lasting 12 weeks, and combined with a calorie-restricted diet.

The main research question is to evaluate the effects of different doses of Phase 2 white kidney bean extract (high dose 1000mg, low dose 700mg) compared to a placebo on weight, body fat mass, body mass index (BMI), waist circumference, hip circumference, and thigh circumference in overweight and moderately obese individuals. Additionally, the study examined the proportion of subjects who lost at least 3% or 5% of their weight at weeks 4, 8, and 12.

The study found that, compared to the placebo group, both high and low doses of Phase 2 white kidney bean extract significantly reduced weight, body fat mass, BMI, waist circumference, hip circumference, and thigh circumference to a certain extent, with the high dose group showing more pronounced effects. These results suggest that Phase 2 white kidney bean extract is an effective and safe adjunctive weight loss supplement.